These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2036477)

  • 21. Erythrocyte membrane phospholipids in psychotic patients.
    Keshavan MS; Mallinger AG; Pettegrew JW; Dippold C
    Psychiatry Res; 1993 Oct; 49(1):89-95. PubMed ID: 8140184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Method for prediction of serum lithium levels.
    Alda M
    Biol Psychiatry; 1988 Jun; 24(2):218-24. PubMed ID: 3134057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alteration of erythrocyte phosphate transport in primary depressive disorders.
    Szentistvanyi I; Janka Z; Rimanoczy A
    J Affect Disord; 1980 Dec; 2(4):229-38. PubMed ID: 6450782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Erythrocyte membrane proteins in psychiatric disorders and controls.
    Fritze J; Koronakis P; Riederer P
    J Affect Disord; 1988; 15(2):187-90. PubMed ID: 2975690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RBC lithium transport in the psychoses.
    Hitzemann R; Mark C; Hirschowitz J; Garver D
    Biol Psychiatry; 1989 Feb; 25(3):296-304. PubMed ID: 2464376
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Erythrocyte sodium pump activity in bipolar affective disorder and other psychiatric disorders.
    Hokin-Neaverson M; Jefferson JW
    Neuropsychobiology; 1989; 22(1):1-7. PubMed ID: 2561681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lithium transport across red cell membrane: a cell membrane abnormality in manic-depressive illness.
    Dorus E; Pandey GN; Shaughnessy R; Gaviria M; Val E; Ericksen S; Davis JM
    Science; 1979 Aug; 205(4409):932-4. PubMed ID: 472716
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Status-dependent neurochemical parameters in schizophrenic and affective diseases].
    Gross G; Huber G; Klosterkötter J; Rao ML; Linz M
    Fortschr Neurol Psychiatr; 1990 Apr; 58(4):154-60. PubMed ID: 1972372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs.
    Maes M; Delange J; Ranjan R; Meltzer HY; Desnyder R; Cooremans W; Scharpé S
    Psychiatry Res; 1997 Jan; 66(1):1-11. PubMed ID: 9061799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Growth hormone response to growth hormone releasing hormone in depression and schizophrenia.
    Peabody CA; Warner MD; Markoff E; Hoffman AR; Wilson DM; Csernansky JG
    Psychiatry Res; 1990 Sep; 33(3):269-76. PubMed ID: 2243902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Erythrocyte membrane transport of amino acid precursors of monoamines in schizophrenic patients. Comparison with depressive patients].
    Azorin JM; Bovier P; Widmer J; Tissot R; Jeanningros R
    Encephale; 1992; 18(5):585-90. PubMed ID: 1364121
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum and red cell folate and affective morbidity in lithium prophylaxis.
    McKeon P; Shelley R; O'Regan S; O'Broin J
    Acta Psychiatr Scand; 1991 Mar; 83(3):199-201. PubMed ID: 2031463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lithium in combination with perphenazine: effect on plasma monoamine metabolites.
    Bowers MB; Mazure CM; Nelson JC; Jatlow PI
    Biol Psychiatry; 1992 Dec; 32(12):1102-7. PubMed ID: 1477190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relation between erythrocyte and plasma lithium concentrations as an index in psychiatric disease.
    Lyttkens L; Söderberg ; Wetterberg L
    Ups J Med Sci; 1976; 81(2):123-8. PubMed ID: 960293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deficient erythrocyte NaK-ATPase activity in different affective states in bipolar affective disorder and normalization by lithium therapy.
    Hokin-Neaverson M; Jefferson JW
    Neuropsychobiology; 1989; 22(1):18-25. PubMed ID: 2561682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyperserotonemia and platelet serotonin uptake and release in schizophrenia and affective disorders.
    Stahl SM; Woo DJ; Mefford IN; Berger PA; Ciaranello RD
    Am J Psychiatry; 1983 Jan; 140(1):26-30. PubMed ID: 6401198
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phenomenology of first-episode psychosis in schizophrenia, bipolar disorder, and unipolar depression: a comparative analysis.
    Rosen C; Marvin R; Reilly JL; Deleon O; Harris MS; Keedy SK; Solari H; Weiden P; Sweeney JA
    Clin Schizophr Relat Psychoses; 2012 Oct; 6(3):145-51. PubMed ID: 23006239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Compliance during lithium treatment, intra-erythrocyte lithium variability, and relapse.
    Harvey NS; Kay R
    J Clin Psychopharmacol; 1991 Dec; 11(6):362-7. PubMed ID: 1770155
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The erythrocyte lithium-plasma lithium ratio in patients with primary affective disorder.
    Ramsey TA; Frazer A; Mendels J; Dyson WL
    Arch Gen Psychiatry; 1979 Apr; 36(4):457-61. PubMed ID: 426613
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission.
    Frommberger UH; Bauer J; Haselbauer P; Fräulin A; Riemann D; Berger M
    Eur Arch Psychiatry Clin Neurosci; 1997; 247(4):228-33. PubMed ID: 9332905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.